At the same time that Pfizer is reporting that it has settled 80 percent of product liability claims involving the smoking cessation drug Chantix, the federal judge in charge of the multidistrict litigation is sending the remaining cases on his ...Read More »
Pfizer has avoided a bellwether trial scheduled to begin this month in the Chantix multidistrict litigation by settling with an Alabama man who claimed he became suicidal after taking the smoking-cessation drug.Read More »
The anti-nausea drug Reglan and its generic counterparts were the drugs most frequently cited in litigation in 2011, according to a consumer watchdog’s latest analysis of Food and Drug Administration statistics.
Tagged with: Accutane adverse events Avandia Bayer Chantix Coumadin drug litigation FDA Food and Drug Administration GlaxoSmithKline Hoffman-LaRoche Institute for Safe Medication Practices Johnson & Johnson Levaquin Pfizer Pradaxa prescription drugs Reglan Wyeth Yasmin YazRead More »
The Food and Drug Administration has announced that the label for the smoking cessation drug Chantix will be updated to address the effect of the drug on users with cardiovascular disease.Read More »
Three personal injury lawsuits were filed against Pfizer Inc. on Thursday, claiming its smoking cessation drug Chantix caused attempted suicides and death. The lawsuits, filed in New York State Supreme Court in Manhattan, claim that at the time the plaintiffs took Chantix, Pfizer did not tell doctors and patients about dangers it allegedly knew were related to the drug, including depression and thoughts of suicide.
Tagged with: ChantixRead More »